Author

M. L. Avent

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:bacteria (other)· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. J. Heffernan· 1 shared D. Paterson· 1 shared F. Sime· 1 shared J. A. Roberts· 1 shared K. L. McCarthy· 1 shared s. naicker· 1 shared S. Wallis· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. J. Heffernan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Evaluating mono and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the Hollow-Fiber Infection Model

M. L. Avent, K. L. McCarthy, F. Sime, s. naicker, A. J. Heffernan, S. Wallis, D. Paterson, J. A. Roberts

This study evaluates the effectiveness of meropenem and amikacin as monotherapy and combination therapy against Pseudomonas aeruginosa isolates using a hollow-fiber infection model, finding improved bacterial killing with combination therapy.

bioRxiv · Dec 23, 2021Pharmacology & Toxicology